Company Profile

AstraZeneca plc (NYSE: AZN)
4:00 PM EST, 12/11/19
Last: $48.19 Change: +0.21 %Change: +0.44% Volume: 3,233,548
Detailed Quote
Open: $ 48.08   Volume: 3,233,548
High: $ 48.50   Yield(%) n/a
Low: $ 48.05   P/E Ratio (ttm): n/a
Dividend ($): n/a   Market Cap ($): 125.89B
EPS ($) n/a   Shares Out: 1.31B
M = Million B = Billion
Price Performance
% Price Change (last 4 weeks): 1.91
% Price Change (last 13 weeks): 10.89
% Price Change (last 26 weeks): 21.81
% Price Change (last 52 weeks): 24.11
% Price Change (year to date): 26.93
Management Effectiveness
Return on Equity (%): 15.69
Return on Assets (%): 3.47
Return on Invested Capital (%): 8.40
Profitability
Gross Profit Margin (%): 71.78
Net Profit Margin (%): 9.76
Operating Profit Margin (%): 8.31
Price & Volume
50-day Moving Average: $46.50
200-day Moving Average: $42.71
Avg. Daily Vol. (last 50 days): 3,066,324
Avg. Daily Vol. (last 200 days): 3,752,793
52-wk high: $49.22
52-wk low: $35.30
Bid: $47.48
Ask: $48.38
Company Information
AstraZeneca Plc is a holding company, which engages in the research, development and manufacturing of pharmaceutical products. The company produces and commercializes medicines for gastrointestinal, cardiovascular, neuroscience, respiratory and inflammation, oncology, and infectious diseases. Its pipeline consists of azd 4831, azd 8601, medi 6012, tagrisso bloom, durvalumab, selumetinib, lyparza polo, epanova, farxiga and brilinta. The company distributes its products under the following brands: Atacand, Crestor, Onglyza, Nexium, Entocort, Losec, Merrem/Meronem, Carbocaine, Citanest, Diprivan, Marcaine/Sensorcaine. AstraZeneca was founded on June 17, 1992 and is headquartered in Cambridge, the United Kingdom.
AstraZeneca plc
Cambridge Biomedical Campus 1 Francis Crick Avenue
Cambridge CA CB2 0AA

Phone: 44.20.3749.5000
Fax: 44.12.2335.2858
http://astrazeneca.com
Per Share Data
Earnings (1year) ($): 0.80
Annual Dividend ($): 1.37
Current P/E Ratio (ttm): n/a
Book Value ($): 4.92
Cash Flow ($): 1.94
Valuation Ratios
Price/Earnings (x): 59.44
Price/Sales (x): 4.36
Price/Book (x): 7.72
Price/Cash Flow (x): 34.30
Financial Strength
Quick Ratio (x): 0.78
Current Ratio (x): 0.95
LT Debt/Equity (x): 139.23
Total Debt/Equity (x): 153.30



Quotes displayed with 15 minutes delay. Market data provided by ICE Data Services ICE Limitations. Powered and implemented by FactSet. Legal Statement. News provided by MT Newswires, a Division of MidnightTrader, Inc. Hemscott equity data provided by Morningstar, Inc. Earnings Calendar and Events Data provided by Wall Street Horizon. © 2018 Wall Street Horizon, Inc.